Seattle Genetics Announced Impressive News as Did Celyad
October 4, 2017
0
Realizing the dream of approval of a small biotech’s lead drug would usually lead a small development-stage firm to either walking on the road to more achievements and growth, or walking in place doing nothing but spending its revenues while no dream materializes. We have seen both possibilities occur time and time again. Seattle Genetics (SGEN) is now a revenue generating biotech. The firm, which …